Elaine M. Castilow, Ph.D.
Affiliations: | 2008 | University of Iowa, Iowa City, IA |
Area:
Immunology, Virology BiologyGoogle:
"Elaine Castilow"Parents
Sign in to add mentor| Steven M. Varga | grad student | 2008 | University of Iowa | |
| (Mechanisms of respiratory syncytial virus vaccine-enhanced disease.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Meyerholz DK, Rodgers J, Castilow EM, et al. (2009) Alcian Blue and Pyronine Y histochemical stains permit assessment of multiple parameters in pulmonary disease models. Veterinary Pathology. 46: 325-8 |
| Meyerholz DK, Griffin MA, Castilow EM, et al. (2009) Comparison of histochemical methods for murine eosinophil detection in an RSV vaccine-enhanced inflammation model. Toxicologic Pathology. 37: 249-55 |
| Castilow EM, Varga SM. (2008) Overcoming T cell-mediated immunopathology to achieve safe RSV vaccination. Future Virology. 3: 445-454 |
| Castilow EM, Legge KL, Varga SM. (2008) Cutting edge: Eosinophils do not contribute to respiratory syncytial virus vaccine-enhanced disease. Journal of Immunology (Baltimore, Md. : 1950). 181: 6692-6 |
| Castilow EM, Meyerholz DK, Varga SM. (2008) IL-13 is required for eosinophil entry into the lung during respiratory syncytial virus vaccine-enhanced disease. Journal of Immunology (Baltimore, Md. : 1950). 180: 2376-84 |
| Castilow EM, Olson MR, Meyerholz DK, et al. (2008) Differential role of gamma interferon in inhibiting pulmonary eosinophilia and exacerbating systemic disease in fusion protein-immunized mice undergoing challenge infection with respiratory syncytial virus. Journal of Virology. 82: 2196-207 |
| Castilow EM, Olson MR, Varga SM. (2007) Understanding respiratory syncytial virus (RSV) vaccine-enhanced disease. Immunologic Research. 39: 225-39 |
| Monick MM, Powers LS, Hassan I, et al. (2007) Respiratory syncytial virus synergizes with Th2 cytokines to induce optimal levels of TARC/CCL17. Journal of Immunology (Baltimore, Md. : 1950). 179: 1648-58 |